β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomised trials

British Medical Journal

Volumn 328, Issue 7441, 2004, Pages 668-672

  Paul, Mical ^a   Benuri Silbiger, Ishay ^a   Soares Weiser, Karla ^a   Leibovici, Leonard ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; AMINOGLYCOSIDE; BETA LACTAM;

CLINICAL TRIAL; COCHRANE LIBRARY; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMBASE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOCOMPETENCE; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; MONOTHERAPY; MORTALITY; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; SIDE EFFECT; TREATMENT FAILURE; COMPARATIVE STUDY; DRUG COMBINATION; TREATMENT OUTCOME;

AMINOGLYCOSIDES; BETA-LACTAMS; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEPSIS; TREATMENT OUTCOME;

EID: 1642395344     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38028.520995.63     Document Type: Review

References (26)

1. Giamarellou H, Zissis NP, Tagari G, Bouzos J. In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1984;25:534-6.
2. Giamarellou H. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. Am J Med 1986;80:126-37.
3. Klastersky J, Meunier-Carpentier F, Prevost JM. Significance of antimicrobial synergism for the outcome of gram negative sepsis. Am J Med Sci 1977;273:157-67.
4. Klastersky J, Zinner SH. Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis 1982;4:294-301.
5. Den Hollander JG, Horrevorts AM, van Goor ML, Verbrugh HA, Mouton JW. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 1997;41:95-100.
6. Mouton JW. Combination therapy as a tool to prevent emergence of bacterial resistance. Infection 1999;27:524-8.
7. Wu YL, Scott EM, Po AL, Tariq VN. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. J Antimicrob Chemother 1999;44:389-92.
8. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
9. Moellering RS. Principles of anti-infective therapy. In: Mandell GL, Bennet JE, Dolin R, eds. Mandell, Douglas, and Bennet's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000.
10. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003;31:462-7.
11. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481-3.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
13. Levison ME. Pharmacodynamics of antibacterial drugs. Infect Dis Clin North Am 2000;14:281-91, vii.
14. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteraemia: outcome correlations in a prospective study of 200 patients. Am J Med 1989;87:540-6.
15. Korvick JA, Bryan CS, Farber B, Beam TR Jr, Schenfeld L, Muder RR, et al. Prospective observational study of Klebsiella bacteraemia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 1992;36:2639-44.
16. Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H, et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteraemia: a prospective, observational study. Antimicrob Agents Chemother 1997;41:1127-33.
17. Siegman-Igra Y, Ravona R, Primerman H, Giladi M. Pseudomonas aeruginosa bacteraemia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis 1998;2:211-5.
18. Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG. Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients. Arch Surg 1999;134:1293-9.
19. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteraemia: clinical features and emergence of antibiotic resistance during therapy. Am Intern Med 1991;115:585-90.
20. Paul M, Soares-Weiser K, Leibovici L. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 2003;326:1111.
21. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74.
22. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379-86.
23. Bailey JA, Virgo KS, DiPiro JT, Nathens AB, Sawyer RG, Mazuski JE. Aminoglycosides for intra-abdominal infection: equal to the challenge? Surgical Infections 2002;3:315-35.
24. Bodey GP, Middleman E, Umsawadi T, Rodriguez V. Infections in cancer patients. Results with gentamicin sulfate therapy. Cancer 1972;29:1697-701.
25. Bayer AS, Bolger AF, Tauben KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936-48.
26. Paul M, Leibovici L, Grozinsky DG, Silbiger I, Soares-Weiser K. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for treating sepsis (protocol for Cochrane Review). Cochrane Library. Issue 2. Oxford: Update Software, 2003.